Test Overview
Clinical Utility
Voltage-Gated Potassium Channel (VGKC) Antibody – Limbic encephalitis (LE) is a paraneoplastic neurological syndrome often associated with small cell lung carcinoma and more rarely with testicular, breast, and other tumors. Clinical hallmarks of paraneoplastic limbic encephalitis are changing mental status, short-term memory impairment, seizures, confusion, and behavioral changes. Hu antibody-negative LE patients usually do not develop symptoms beyond the limbic system and appear to improve more often after treatment of the cancer than those who have Hu antibodies, suggesting that the pathogenesis of the LE in both groups could be different. Recent studies have detected antibodies to voltage-gated potassium channels (VGKC) in patients with LE, with and without associated tumors. Neurological symptoms were found to improve with a reduction of VGKC antibody levels.
Method
Radioimmunoassay (RIA)
Result Included
Voltage-Gated Potassium Channel (VGKC) Antibodies
Specimen
Specimen Type
SerumVolume
Sample Volume
1.0 mL
Minimum Volume
0.5 mL
Collection & Handling
Handling Information
Store and send frozen
Stability
| Ambient | Refrigerated | Frozen |
|---|---|---|
| 48 hours | 48 hours | 73 days |
Performance & Interpretation
Turnaround Time
14 days
Results
-
Voltage-Gated Potassium Channel (VGKC) Antibodiespmol/L<80
Referral Location
Out-of-Country
Interface & Setup
HL7 Interface Codes
| Order Code | Result Name | Result Codes | Units |
|---|---|---|---|
| VGKC S | VOLTAGE GATED POTASSIUM CHANNEL (VGKC) AB | 63125 | pmol/L |
Test Version
Last Updated
2019-11-28